Výsledky vyhledávání - "E C, Tufekci"

The ovarian cancers in geriatric population: the validity of inflammatory markers, malignancy risk indices 1, 2, 3, 4, and CA-125 levels in malignancy discrimination of adnexal masses

Autor: F, Vural, N, Aka, S, Ertas, G, Kose, E C, Tufekci

Publikováno v: European journal of gynaecological oncology. 37(6)

To investigate the predictive value of the Risk of Malignancy Index (RMI), CA-125, and inflammatory markers in discriminating ovarian cancers (OCs).The postmenopausal (PM) women (n= 139) with adnexal masses who un- derwent surgery were included. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c0c5e6d42b39808fe28bb7d2defa7f9a
https://pubmed.ncbi.nlm.nih.gov/29943934

Zobrazit plný text záznamu

Efficacy and acceptability of risedronate 5 mg daily compared with 35 mg once weekly for the treatment of postmenopausal osteoporosis

Autor: E. C. Tufekci, O. Batur, Erdin Ilter, H. Karalok

WOS: 000237935100007
PubMed ID: 16698659
Objective Risedronate is a bisphosphonate used in the treatment of osteoporosis. It has a strong effect in inhibiting osteoclast activity. The primary objective of this study was to evaluate the effe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31353c48ec37ec9db1cf9402bb94de34
https://hdl.handle.net/20.500.12415/7301

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání